Literature DB >> 17593346

Dilinoleoyl-phosphatidic acid mediates reduced IRS-1 tyrosine phosphorylation in rat skeletal muscle cells and mouse muscle.

R Cazzolli1, T W Mitchell, J G Burchfield, D J Pedersen, N Turner, T J Biden, C Schmitz-Peiffer.   

Abstract

AIMS/HYPOTHESIS: Insulin resistance in skeletal muscle is strongly associated with lipid oversupply, but the intracellular metabolites and underlying mechanisms are unclear. We therefore sought to identify the lipid intermediates through which the common unsaturated fatty acid linoleate causes defects in IRS-1 signalling in L6 myotubes and mouse skeletal muscle.
MATERIALS AND METHODS: Cells were pre-treated with 1 mmol/l linoleate for 24 h. Subsequent insulin-stimulated IRS-1 tyrosine phosphorylation and its association with the p85 subunit of phosphatidylinositol 3-kinase were determined by immunoblotting. Intracellular lipid species and protein kinase C activation were modulated by overexpression of diacylglycerol kinase epsilon, which preferentially converts unsaturated diacylglycerol into phosphatidic acid, or by inhibition of lysophosphatidic acid acyl transferase with lisofylline, which reduces phosphatidic acid synthesis. Phosphatidic acid species in linoleate-treated cells or muscle from insulin-resistant mice fed a safflower oil-based high-fat diet that was rich in linoleate were analysed by mass spectrometry.
RESULTS: Linoleate pretreatment reduced IRS-1 tyrosine phosphorylation and p85 association. Overexpression of diacylglycerol kinase epsilon reversed the activation of protein kinase C isoforms by linoleate, but paradoxically further diminished IRS-1 tyrosine phosphorylation. Conversely, lisofylline treatment restored IRS-1 phosphorylation. Mass spectrometry indicated that the dilinoleoyl-phosphatidic acid content increased from undetectable levels to almost 20% of total phosphatidic acid in L6 cells and to 8% of total in the muscle of mice fed a high-fat diet. Micelles containing dilinoleoyl-phosphatidic acid specifically inhibited IRS-1 tyrosine phosphorylation and glycogen synthesis in L6 cells. CONCLUSIONS/
INTERPRETATION: These data indicate that linoleate-derived phosphatidic acid is a novel lipid species that contributes independently of protein kinase C to IRS-1 signalling defects in muscle cells in response to lipid oversupply.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593346     DOI: 10.1007/s00125-007-0709-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  44 in total

1.  Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats.

Authors:  L H Storlien; D E James; K M Burleigh; D J Chisholm; E W Kraegen
Journal:  Am J Physiol       Date:  1986-11

2.  Increased protein kinase C theta in skeletal muscle of diabetic patients.

Authors:  S I Itani; W J Pories; K G Macdonald; G L Dohm
Journal:  Metabolism       Date:  2001-05       Impact factor: 8.694

Review 3.  Signaling functions of phosphatidic acid.

Authors:  Xuemin Wang; Shivakumar Pattada Devaiah; Wenhua Zhang; Ruth Welti
Journal:  Prog Lipid Res       Date:  2006-03-15       Impact factor: 16.195

4.  A role for protein phosphatase 2A-like activity, but not atypical protein kinase Czeta, in the inhibition of protein kinase B/Akt and glycogen synthesis by palmitate.

Authors:  R Cazzolli; L Carpenter; T J Biden; C Schmitz-Peiffer
Journal:  Diabetes       Date:  2001-10       Impact factor: 9.461

Review 5.  Lisofylline: a potential lead for the treatment of diabetes.

Authors:  Zandong Yang; Meng Chen; Jerry L Nadler
Journal:  Biochem Pharmacol       Date:  2005-01-01       Impact factor: 5.858

Review 6.  Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply.

Authors:  C Schmitz-Peiffer
Journal:  Cell Signal       Date:  2000-10       Impact factor: 4.315

7.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration.

Authors:  E W Kraegen; D E James; L H Storlien; K M Burleigh; D J Chisholm
Journal:  Diabetologia       Date:  1986-03       Impact factor: 10.122

9.  Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B.

Authors:  Suzanne Stratford; Kyle L Hoehn; Feng Liu; Scott A Summers
Journal:  J Biol Chem       Date:  2004-06-25       Impact factor: 5.157

10.  Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.

Authors:  L J Goodyear; F Giorgino; L A Sherman; J Carey; R J Smith; G L Dohm
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

View more
  11 in total

1.  Over-expression of LYRM1 inhibits glucose transport in rat skeletal muscles via attenuated phosphorylation of PI3K (p85) and Akt.

Authors:  Chunzhao Kou; Xinguo Cao; Dani Qin; Chenbo Ji; Jingai Zhu; Chunmei Zhang; Chun Zhu; Chunlin Gao; Ronghua Chen; Xirong Guo; Min Zhang
Journal:  Mol Cell Biochem       Date:  2010-11-12       Impact factor: 3.396

2.  Time-dependent effects of Prkce deletion on glucose homeostasis and hepatic lipid metabolism on dietary lipid oversupply in mice.

Authors:  K Raddatz; N Turner; G Frangioudakis; B M Liao; D J Pedersen; J Cantley; D Wilks; E Preston; B D Hegarty; M Leitges; M J Raftery; T J Biden; C Schmitz-Peiffer
Journal:  Diabetologia       Date:  2011-02-24       Impact factor: 10.122

3.  Saturated- and n-6 polyunsaturated-fat diets each induce ceramide accumulation in mouse skeletal muscle: reversal and improvement of glucose tolerance by lipid metabolism inhibitors.

Authors:  G Frangioudakis; J Garrard; K Raddatz; J L Nadler; T W Mitchell; C Schmitz-Peiffer
Journal:  Endocrinology       Date:  2010-07-21       Impact factor: 4.736

Review 4.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

Review 5.  Lipid oversupply, selective insulin resistance, and lipotoxicity: molecular mechanisms.

Authors:  Jose Antonio Chavez; Scott A Summers
Journal:  Biochim Biophys Acta       Date:  2009-09-29

6.  Phosphatidylinositol-4-phosphate 5-kinase isoforms exhibit acyl chain selectivity for both substrate and lipid activator.

Authors:  Yulia V Shulga; Richard A Anderson; Matthew K Topham; Richard M Epand
Journal:  J Biol Chem       Date:  2012-09-01       Impact factor: 5.157

7.  Substrate specificity of diacylglycerol kinase-epsilon and the phosphatidylinositol cycle.

Authors:  Yulia V Shulga; Matthew K Topham; Richard M Epand
Journal:  FEBS Lett       Date:  2011-11-19       Impact factor: 3.864

8.  Targeting ceramide synthesis to reverse insulin resistance.

Authors:  Carsten Schmitz-Peiffer
Journal:  Diabetes       Date:  2010-10       Impact factor: 9.461

Review 9.  MicroRNAs and Oxidative Stress: An Intriguing Crosstalk to Be Exploited in the Management of Type 2 Diabetes.

Authors:  Teresa Vezza; Aranzazu M de Marañón; Francisco Canet; Pedro Díaz-Pozo; Miguel Marti; Pilar D'Ocon; Nadezda Apostolova; Milagros Rocha; Víctor M Víctor
Journal:  Antioxidants (Basel)       Date:  2021-05-19

Review 10.  Protein kinase C function in muscle, liver, and beta-cells and its therapeutic implications for type 2 diabetes.

Authors:  Carsten Schmitz-Peiffer; Trevor J Biden
Journal:  Diabetes       Date:  2008-07       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.